References
- Lin M-E, Herr DR, Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat 2010;91:130–8
- Noguchi K, Herr D, Mutoh T, Chun J. Lysophosphatidic acid (LPA) and its receptors. Curr Opin Pharmacol 2009;9:15–23
- Ishii S, Noguchi K, Yanagida K. Non-Edg family lysophosphatidic acid (LPA) receptors. Prostaglandins Other Lipid Mediat 2009;89:57–65
- Fukushima N, Ishii I, Contos JA, et al. Lysophospholipid receptors. Annu Rev Pharmacol Toxicol 2001;41:507–34
- Yu S, Murph MM, Lu Y, et al. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. J Natl Cancer Inst 2008;100:1630–42
- Okabe K, Hayashi M, Kato K, et al. Lysophosphatidic acid receptor-3 increases tumorigenicity and aggressiveness of rat hepatoma RH7777 cells. Mol Carcinog 2013;52:247–54
- Hayashi M, Okabe K, Kato K, et al. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells. Cancer Lett 2012;316:91–6
- Hayashi M, Okabe K, Yamawaki Y, et al. Loss of lysophosphatidic acid receptor-3 enhances cell migration in rat lung tumor cells. Biochem Biophys Res Commun 2011;405:450–4
- Diamanti-Kandarakis E, Bourguignon J-P, Giudice LC, et al. Endocrine-disrupting chemicals: an endocrine society scientific statement. Endocrine Rev 2009;30:293–342
- Krishnan AV, Stathis P, Permuth SF, et al. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 1993;132:2279–86
- Soto AM, Justicia H, Wray JW, Sonnenschein C. p-Nonylphenol: an estrogenic xenobiotic released from “modified” polystyrene. Environ Health Perspect 1991;92:167–73
- Tanabe E, Shibata A, Inoue S, et al. Regulation of cell motile activity through the different induction of LPA receptors by estrogens in liver epithelial WB-F344 cells. Biochem Biophys Res Commun 2012;428:105–9
- Asimalopoulos AG, Thomaidis NS, Koupparis MA. Recent trends in biomonitoring of bispheol A, 4-t-octylphenol, and 4-nonylphenol. Toxicol Lett 2012;210:141–54
- Alonso-Magdlena P, Ropero AB, Soriano S, et al. Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways. Mol Cell Endocrinol 2012;355:201–7
- Okabe K, Kato K, Teranishi M, et al. Induction of lysophosphatidic acid receptor-3 by 12-O-tetradecanoylphorbol-13-acetate stimulates cell migration of rat liver cells. Cancer Lett 2011;309:236–42
- Shano S, Hatanaka K, Ninose S, et al. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation. Biochim Biophys Acta 2008;1783:748–59
- Shibata A, Tanabe E, Inoue S, et al. Hydrogen peroxide stimulates cell motile activity through LPA receptor-3 in liver epithelial WB-F344 cell. Biochem Biophys Res Commun 2013;433:317–21
- Tsujiuchi T, Okabe K, Fukushima N. Genetic and epigenetic alterations of lysophosphatidic acid receptor genes in rodent tumors by experimental models. J Toxicol Pathol 2011;24:143–8
- Obo Y, Yamada T, Furukawa M, et al. Frequent mutations of lysophosphatidic acid receptor-1 gene in rat liver tumors. Mutat Res 2009;660:47–50
- Yamada T, Furukawa M, Hotta M, et al. Mutations of lysophosphatidic acid receptor-1 gene during progression of lung tumors in rats. Biochem Biophys Res Commun 2009;378:424–7
- Yotti LP, Chang CC, Trosko JE. Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter. Science 1979;208:1089–91
- Fischer DJ, Nusser N, Virag T, et al. Short-chain phosphatidates are subtype-selective antagonists of lysophosphatidic acid receptors. Mol Pharmacol 2001;60:776–84